Antimicrobial resistance erodes the effectiveness of the antibiotics that underpin modern medicine, causing millions of deaths annually. A broken antibiotic-development market and the evolutionary inevitability of resistance make it a slow-burn, hard-to-solve global threat.
1 approved
Antimicrobial resistance (AMR) threatens to unwind a century of medical progress, rendering routine infections, surgery, and chemotherapy dangerous once again. This founding report quantifies the global burden, diagnoses the broken antibiotic-development market at the heart of the problem, and lays out a research and policy agenda spanning stewardship, surveillance, novel incentive models, and the One Health interface.
No community drafts in review
No drafts are currently under review for this problem. Start one and become part of the solution.
No open questions yet
Be the first to ask what's missing on this problem.
No activity on this problem yet.
Be the first to back this work.
Sponsors have no editorial influence over which documents are accepted on this problem. Learn more